Data from the phase 3 ENVISION trial demonstrate the potential of UGN-102 as an effective and durable nonsurgical treatment for patients with low-grade, intermediate-risk non–muscle-invasive bladder ...

"Our retrospective cohort study found no significant association between preterm birth and the diagnosis of autism spectrum ...

Background Early heart failure (HF) diagnosis is crucial to ensure that optimal guideline-directed medical therapy (GDMT) is ...

Type 2 inflammation (T2I) was highly predictive of the likelihood to have a surgery performed due to otitis media with ...

Cancer incidence continues to rise for many common cancers—especially for women. The incidence rate for women younger than 50 has increased from 51% higher than men in 2002 to 82% higher in 2021 (the ...

The weighted incidence rates per 100 person-years of clinical outcomes were calculated. The risk of clinical outcomes for the groups were evaluated using Kaplan-Meier survival analysis with the ...

Meta's decision to disband its fact-checking program, a cornerstone of its efforts to combat misinformation, has highlighted the growing influence of Joel Kaplan, the company's new global policy ...

By Cecilia Kang Joel Kaplan, Meta’s new chief global affairs officer, played a leading role in Tuesday’s content moderation announcement. In an exclusive interview on “Fox and Friends,” Mr ...

JOSHUA KAPLAN: They have a — yes, they have a spreadsheet. Every member in AP3 got a spreadsheet of the sheriffs in their state, was told to reach out to them, mark who’s friendly, who’s not.

All eyes are now on his replacement, Joel Kaplan, who’s worked at the company since 2011. He was most recently its vice president of global public policy and leader of its DC office, although he ...